The Article related to benzenesulfonamide benzyl phenyl preparation antiviral, Benzene, Its Derivatives, and Condensed Benzenoid Compounds: Sulfenic, Sulfinic, and Sulfonic Acids and Derivatives and other aspects.HPLC of Formula: 15258-72-7
On October 4, 2007, Urban, Andreas; Brohm, Dirk; Birkmann, Alexander; Schohe-Loop, Rudolf; Koletzki, Diana; Harrenga, Axel; Stoll, Friederike; Mundt, Stefan; Paulsen, Daniela published a patent.HPLC of Formula: 15258-72-7 The title of the patent was Substituted N-benzyl-N-phenylbenzenesulfonamides as antiviral agents, their preparation, pharmaceutical compositions, and use in therapy. And the patent contained the following:
The invention relates to substituted N-benzyl-N-phenylbenzenesulfonamides of formula I, which are antiviral agents. In compounds I, R1 is OH or NR9R10, where R9 and R10 are independently selected from H, C1-6 alkyl, (un)substituted benzyl, (un)substituted phenethyl, and C3-6 cycloalkyl; R2 is H, halo, cyano, OH, NH2, CF3, CF3O, (un)substituted C1-4 alkyl, (un)substituted C1-4 alkoxy, (un)substituted C1-4 alkylamino, or 5- to 7-membered heterocyclylamino, or R1R2 is -OCH2-; and R3 is H, halo, cyano, OH, NH2, CF3, CF3O, (un)substituted C1-4 alkyl, (un)substituted C1-4 alkoxy, (un)substituted C1-4 alkylamino, or (un)substituted 5- to 7-membered heterocyclylamino. Further, in compounds I, R4 is halo, cyano, Me, Et, or cyclopropyl; R5 is selected from H, (un)substituted C1-4 alkyl, (un)substituted C2-4 alkenyl, (un)substituted C1-4 alkoxy, (un)substituted C1-4 alkylthio, (un)substituted C1-4 alkylamino, and (un)substituted 5- to 10-membered heteroaryl-Y-CH2, where Y is -O-, -S-, or -N(R11)-, and R11 is H, C1-4 alkyl, or C3-6 cycloalkyl; R6 is halo, cyano, nitro, Me, Et, CF3, CF3O, or 2-cyanovinyl; R7 is selected from H, (un)substituted C1-4 alkyl, (un)substituted C2-4 alkenyl, (un)substituted C1-4 alkoxy, (un)substituted C1-4 alkylthio, and C1-4 alkylamino; and R8 is halo, cyano, nitro, Me, Et, CF3, or CF3O; including salts and solvates thereof. The invention also relates to the preparation of I, pharmaceutical compositions comprising a compound I and a pharmaceutically acceptable adjuvant and optionally comprising an addnl. active ingredient, as well as to the use of the compositions for the treatment of viral infections, especially against hepatitis C viruses. Amidation of 3-chlorobenzenesulfonyl chloride with 6-amino-1,3-dihydroisobenzofuran-1-one followed by N-alkylation with 2,6-dichlorobenzyl bromide resulted in the formation of benzenesulfonamide II. The compounds of the invention are antiviral agents, e.g., compound II expressed an EC50 value of 1 μM and a CC50 value for cytotoxicity of more than 100 μM. The experimental process involved the reaction of 1-Chloro-2-(chloromethyl)-3-nitrobenzene(cas: 15258-72-7).HPLC of Formula: 15258-72-7
The Article related to benzenesulfonamide benzyl phenyl preparation antiviral, Benzene, Its Derivatives, and Condensed Benzenoid Compounds: Sulfenic, Sulfinic, and Sulfonic Acids and Derivatives and other aspects.HPLC of Formula: 15258-72-7
Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics